High-Throughput a1-Acid Glycoprotein Binding Assay
The 20 min high-throughput assay estimates the binding of drugs to a1-acid glycoprotein (AGP) and is essential for predicting plasma
Read moreThe 20 min high-throughput assay estimates the binding of drugs to a1-acid glycoprotein (AGP) and is essential for predicting plasma
Read moreAccelerating Immunoassay Development With Automated Storage, Filling and Labeling – Case Study An HTI Automation & Mabtech Case Study The
Read moreThis high-throughput microsomal binding assay, requires only 20 min to measure the affinity of drugs to human microsomal membranes and
Read moreSignatope provides advanced assay panels designed to precisely detect and quantify clinically relevant biomarkers for drug-induced kidney injury (DIKI). The
Read moreSignatope offers custom assay and antibody development services under the SignaXIMTM trademark, catering to the specific needs of pharmaceutical and
Read moreSignaXENOTM is an advanced range of CYP450 metabolism assays developed for assessing the potential of substances to activate drug metabolism-related
Read moreSignatope has developed cutting-edge assay panels designed to accurately quantify clinically relevant biomarkers for drug-induced liver injury (DILI). These panels
Read moreDetermination of the Plasma Protein Binding of Liraglutide Using the EScalate* Equilibrium Shift Assay A Sovicell White Paper Evaluation of
Read moreThe unique rapid plasma protein binding assay for sticky and tightly bound compounds can be used with plasma from any
Read moreThe fast high-throughput Assay for Brain Tissue Binding developed by Sovicell and GSK is ready to use and requires only
Read more